RTX’s Raytheon has completed a ballistic test of the US Army’s Next Generation Short Range Interceptor (NGSRI), the missile intended to replace the Stinger surface-to-air system.

The ballistic test confirmed the interceptor’s capability to track drone targets and launch from a man-portable system.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Raytheon financed the trial to show technical progress and gather essential data prior to the programme’s forthcoming flight demonstration.

In February last year, Raytheon completed 10 subsystem demonstrations of its NGSRI solution for the US Army.

Raytheon Land and Air Defense Systems president Tom Laliberty said: “Raytheon’s investment in NGSRI demonstrates the company’s strong partnership with the US Army and our commitment to equipping service members with this advanced capability.

“We continue to prioritise rapid learning and testing to ensure the Army receives a cost-effective and technologically superior interceptor.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Raytheon has also collaborated with Northrop Grumman in 2025 to conduct multiple tests of Highly Loaded Grain (HLG) solid rocket motors.

HLG technology is designed to extend burn time and increase energy output compared to traditional rocket motors, potentially increasing the operational range of the NGSRI.

RTX said that Raytheon is working with the US Army to meet the programme schedule.

The NGSRI is billed as a faster missile with improved performance against aerial threats compared to current interceptors.

It can be launched from both vehicles and shoulder-mounted systems and is engineered to fit both the Stinger Vehicle Universal Launch mechanism and existing man-portable platforms.

Raytheon has developed the NGSRI for use by the US Army and Marine Corps, drawing on over six decades of air defence expertise.